InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,167.00
(
0.24%
)
Post# of 37328
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Steve1HD1

Send PM Follow Ignore
Followers 2
Posts 236
Boards Moderated 0
Alias Born 12/08/2011

Steve1HD1

Re: naturalborninvestor post# 17695

Monday, 02/15/2016 7:49:56 AM

Monday, February 15, 2016 7:49:56 AM

Post# of 37328
stand-alone test

Commercially available tests from Great Basin include low-plex tests for Clostridium
difficile (C. diff) and Group B Streptococcus (GBS). The Company is awaiting 510(k)
clearances from the U.S. Food & Drug Administration (FDA) for their Shiga Toxin Direct
Test, which, upon FDA clearance, will be the only stand-alone test to provide CDCrecommended

source

http://gbscience.com/wp-content/uploads/Great-Basin-Ends-January-with-201-Customers_Final.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up